We visited Marsden House because during our inspection on 8 November 2011 we identified concerns about how the staff looked after medicines for the people who lived there. We spoke with three of the 13 people who lived at Marsden House, two of whose records we had looked at. As well as the 13 permanent residents another person was staying for respite care. The three people we spoke with all had some difficulty communicating, possibly related to a dementia type illness. This meant that we were unable to find out their views on how the care staff looked after their medicines.
At this inspection the safe handling of medicines was assessed by a pharmacist inspector and a compliance inspector. We wanted to see if the action plan the provider gave us following our inspection in November 2011 had led to appropriate arrangements being put in place. We looked at the storage of medicines and a sample of three people's medicine records. We met six of the care staff working during the morning and afternoon shifts. Two senior carers assisted us with the inspection.
After the inspection we contacted a community services manager for department of mental health for older people at the 2gether NHS Foundation Trust Herefordshire involved in the treatment of one of the people who lived at the home.
We found that the arrangements had been improved in areas such as staff training in medicines and the safe keeping of medicines. We looked at three people's available medicines and their Medicine Administration Record charts (MAR charts). We found that appropriate arrangements were in place for recording when prescribed medicines had been administered.
We looked at one person's care plan and MAR charts and spoke to two senior carers. We found that this person had run out of one of their prescribed medicines in March 2012 and the relevant health professionals had not been told for 28 days. We found that there was a further delay of three weeks while health professionals reassessed the person's needs and made a decision about future treatment. During these three weeks the provider issued written instructions to care staff to start administering this medication again by using a supply held in the home prescribed to another person. The provider did this without the permission of a health professional.
The patient information leaflet supplied with the medicine by the manufacturer stated, 'If you miss more than three days of applying Exelon Patch, call your healthcare provider before putting on another patch'. The provider instructed care staff to cut the medication patches in half and apply half a patch each day. The manufacturer's safety instructions state in bold 'The patch should not be cut or folded sharply'.
After three days the medication was stopped again. A senior carer told us this was because some staff had raised concerns and thought what they had been instructed to do was not safe. We asked if there was a record of who made this decision but this carer told us there was not. This carer told us the relative of the person concerned was told the supply of patches had run out, but not that another person's patches had been used for three days. The manager of the health professional involved in this person's treatment confirmed their department had been told at a visit that the supply had run out 28 days previously, but that they had not been told that another person's patches had been used for three days. They told us that they would not have approved the use of someone else's medicine.
These events meant that the provider had failed to protect people in the care of Marsden House against the risks associated with the unsafe use and management of medicines. This was because the provider had not made appropriate arrangements for the obtaining and safe administering of medicines. As a result, this service user went without their prescribed medication for a period of 54 days and was administered another person's medicines for three of these days in an unsafe way and without the permission of a health professional.